Clinical Trials Logo

Anxiety Disorder clinical trials

View clinical trials related to Anxiety Disorder.

Filter by:

NCT ID: NCT00106860 Completed - Anxiety Disorder Clinical Trials

A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder

Start date: March 2005
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the safety and effectiveness of the experimental drug, a benzodiazepine drug, in long-term use and the effects on quality of life, social and occupational functioning, sleep, and daytime sedation in subjects with anxiety disorder.

NCT ID: NCT00102427 Completed - Panic Disorder Clinical Trials

Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders

Start date: July 2000
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if primary care patients with panic and/or generalized anxiety disorder can benefit from a telephone-based collaborative care intervention.

NCT ID: NCT00097708 Completed - Anxiety Disorder Clinical Trials

Experimental Medication For the Treatment of Generalized Anxiety Disorder

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.

NCT ID: NCT00057733 Completed - Depression Clinical Trials

Stress Management Training in Patients Undergoing Radiation Therapy for Cancer

Start date: February 2003
Phase: N/A
Study type: Interventional

RATIONALE: Stress management techniques such as muscle relaxation, guided imagery, and abdominal breathing may improve quality of life and decrease emotional distress in patients who are undergoing radiation therapy for cancer. PURPOSE: Randomized clinical trial to determine the effectiveness of stress management training in helping cancer patients cope with the emotional distress of radiation therapy.

NCT ID: NCT00025844 Completed - Anxiety Disorder Clinical Trials

Fear Conditioning Using Computer-Generated Virtual Reality

Start date: October 22, 2001
Phase: N/A
Study type: Observational

The purpose of this study is to use a computer-generated virtual reality environment to study fear conditioning. Fear conditioning is used to explore the causes and persistence of anxiety and anxiety disorders. When confronted with fearful or unpleasant events, people can develop fear of specific cues that were associated with these events as well as to the environmental context in which the events occurred via a process called classical or aversive conditioning. Advances in computer-generated visual stimulations could facilitate the design of new aversive conditioning studies. This study will develop a virtual reality environment to examine human contextual fear conditioning in the laboratory. During the procedure, moderately painful stimuli will be administered. Participants in this study will be screened with a medical history, physical examination, psychiatric evaluation, and hearing test. Participants will wear headphones and special goggles that will enable them to view a virtual reality environment. Measures will be taken during the study to see how the brain adapts to environmental stimuli.

NCT ID: NCT00022074 Completed - Breast Cancer Clinical Trials

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Start date: July 2001
Phase: N/A
Study type: Interventional

RATIONALE: Gabapentin may be effective for the control of hot flashes. It is not yet known if gabapentin is effective in treating hot flashes. PURPOSE: Randomized clinical trial to study the effectiveness of gabapentin in controlling hot flashes in women who have breast cancer.

NCT ID: NCT00014482 Completed - Depression Clinical Trials

Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation

Start date: December 2000
Phase: N/A
Study type: Interventional

RATIONALE: Music therapy may be effective in relieving pain and emotional distress in patients who are undergoing cancer therapy. PURPOSE: Randomized trial to determine the effectiveness of music therapy to ease pain and emotional distress in patients with hematologic cancer who are undergoing high-dose therapy and stem cell transplantation.

NCT ID: NCT00005850 Completed - Depression Clinical Trials

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Start date: August 2001
Phase: Phase 2
Study type: Interventional

This trial is designed to test the efficacy of fluoxetine to improve patient's quality of life during chemotherapy. An innovative application of a selective serotonin reuptake inhibitor may modulate the effects of fatigue, anxiety and depression which worsen quality of life.

NCT ID: NCT00004373 Completed - Panic Disorder Clinical Trials

Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety

Start date: March 1997
Phase: Phase 2
Study type: Interventional

OBJECTIVES: I. Determine whether the benzodiazepine alprazolam reinforces self-medication behavior in anxious patients with varying histories of using other drugs. II. Establish outpatient methods for the study of self-medication and drug reinforcement in patients vulnerable to prescription drug abuse or dependence. III. Evaluate the influence of alcohol and other non-prescription drug use as determinants of vulnerability in these patients. IV. Identify personality, attitudinal, or other variables that might predict different patterns of self-medication. V. Assess the effects of cognitive-behavioral therapy on alprazolam self-medication.

NCT ID: NCT00004367 Completed - Panic Disorder Clinical Trials

Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia

Start date: May 2000
Phase: N/A
Study type: Interventional

OBJECTIVES: I. Determine whether the prevalence of abnormalities on clinical vestibular (balance) tests is higher in panic disorder with agoraphobia than in uncomplicated panic disorder and nonpanic anxiety disorder. II. Determine whether the prevalence of abnormalities on audiological tests of cochlear or brainstem function is elevated in panic disorder without agoraphobia or nonpanic anxiety disorder. III. Determine whether symptom patterns can be identified that are indicative of vestibular abnormalities in panic disorder. IV. Determine whether vestibular dysfunction can be induced by psychosomatic mechanisms.